NCT04900792 2025-12-03
XACT-Fe-GBM-01
University of Iowa
Phase 1 Active not recruiting
Clinical Trials
6 trialsNCT02631733 2025-02-10
Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01770353 2019-11-27
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
Ipsen
Phase 1 Completed
NCT01296139 2018-07-05
Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00769093 2017-04-21
Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy
OHSU Knight Cancer Institute
Phase 1 Terminated
NCT02689401 2016-05-13
MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer
Dana-Farber Cancer Institute
Phase 1 Withdrawn